查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1739311

全球人工智慧醫療診斷工具市場

Artificial Intelligence-based Medical Diagnostic Tools
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球人工智慧醫療診斷工具市場規模將達48億美元

全球人工智慧醫療診斷工具市場規模預計在2024年為17億美元，預計到2030年將達到48億美元，2024年至2030年的複合年成長率為19.0%。人工智慧軟體是本報告分析的細分市場之一，預計其複合年成長率為19.6%，到分析期結束時規模將達到23億美元。人工智慧服務細分市場在分析期間的複合年成長率預計為17.4%。

美國市場規模估計為 4.457 億美元，中國市場預計複合年成長率為 17.9%

美國基於人工智慧的醫療診斷工具市場規模預計在2024年達到4.457億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到7.393億美元，在2024-2030年的分析期內，複合年成長率為17.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為17.4%和16.3%。在歐洲，預計德國市場的複合年成長率約為12.9%。

全球基於人工智慧的醫療診斷工具市場—主要趨勢與促進因素摘要

為什麼基於人工智慧的診斷工具正在重塑醫療決策

基於人工智慧的醫療診斷工具正在改變臨床工作流程和醫療服務，為眾多醫學學科提供快速、準確且可擴展的診斷支援。這些工具利用機器學習 (ML)、深度學習和自然語言處理 (NLP) 分析各種臨床數據，包括放射影像、病理切片、基因組序列、電子健康記錄(EHR) 和實驗室檢測結果，從而識別模式、檢測異常並產生鑑別診斷，其一致性和速度均高於傳統方法。隨著全球醫療系統努力應對日益成長的患者數量、人力短缺以及精準醫療的需求，人工智慧診斷正逐漸成為提高診斷準確性和減少護理差異的重要輔助。

與依賴靜態規則集的傳統決策支援系統不同，人工智慧工具透過研究通常由專家註釋的大型資料集不斷學習和發展，從而即時提供基於證據的洞察。這些系統正被整合到放射科實驗室、病理科實驗室、基層醫療診所和遠端醫療平台中，以支援早期疾病檢測、分流和風險分層。從腫瘤科、循環系統到眼科、皮膚科，人工智慧能夠快速識別複雜的病理，減少診斷延遲，提高臨床效率，並促進及時干預，從而改善患者預後。

人工智慧演算法如何提高成像、基因組學和多模態數據的診斷效能？

以人工智慧為基礎的診斷工具正在透過高精度解讀電腦斷層掃描、核磁共振成像 (MRI)、X 光、乳房 X 光檢查和超音波影像，徹底革新醫學影像。深度卷積類神經網路(CNN) 廣泛應用於影像分割、特徵提取和病變分類，在肺結節檢測、乳癌篩檢和糖尿病視網膜病變分級等特定任務中，其表現往往優於人類專家。這些工具不僅加快了影像解讀速度，還能透過熱圖和可解釋的特徵來突顯異常情況，進而提高臨床可靠性和工作流程整合度。

在基因組學領域，人工智慧正在幫助解讀複雜的基因數據，從而輔助腫瘤疾病風險預測、罕見疾病診斷和治療方法選擇。自然語言處理演算法能夠從非結構化的電子健康檔案 (EHR)、實驗室報告和臨床記錄中提取臨床相關數據，從而創建全面的患者檔案，並檢測出人工審核可能遺漏的診斷訊號。結合影像、實驗室值、基因標記和患者病歷的多模態人工智慧模型因其能夠產生全面的診斷見解和個人化治療建議而日益受到重視。這些進步正在推動診斷工具超越單一模態的精準診斷，邁向支持基於價值、數據驅動醫療的整合精準診斷。

哪些市場需求正在加速成長，哪些臨床領域正在引領人工智慧診斷的應用？

受醫療保健數位化不斷提高、政策對人工智慧整合的支持以及臨床醫生接受度不斷提高的推動，美國、歐洲和亞太地區對基於人工智慧的醫療診斷工具的需求正在迅速成長。北美在採用方面處於領先地位，這得益於先進的醫療IT基礎設施、優惠的報銷試點以及充滿活力的新興企業、學術機構和監管途徑（例如 FDA 基於人工智慧/機器學習的軟體即醫療器材框架）的生態系統。在歐洲，透過國家醫療保健系統和歐盟支持的創新計劃，採用率正在不斷成長。在亞太地區，官民合作關係關係和以人工智慧為中心的醫療改革的推動，中國、韓國、日本和印度等國家正在醫院和診斷實驗室加速採用人工智慧。

放射學仍然是最活躍的應用領域，人工智慧工具解決了診斷積壓問題並實現了遠端成像。病理學和腫瘤學是主要的成長領域，人工智慧可協助進行腫瘤分類、突變分析和切片檢查分析。在循環系統，人工智慧正被用於心電圖解讀、心臟衰竭風險預測和基於影像的結構評估。在眼科和皮膚科領域，人工智慧正被用於糖尿病眼部篩檢和皮膚病變分析，通常採用行動和雲端基礎解決方案。感染疾病檢測（例如新冠肺炎、結核病）和照護現場的新興應用正在惠及農村和服務不足的醫療機構，這些機構的臨床醫生短缺問題持續存在。

是什麼推動了基於人工智慧的醫療診斷工具的全球成長？

基於人工智慧的醫療診斷工具的成長源於醫療數位化的整合、日益加重的慢性病負擔，以及對及時、經濟高效的大規模診斷的需求。關鍵促進因素是結構化和非結構化臨床數據的日益普及，加上雲端運算、邊緣人工智慧和聯邦學習的進步，從而實現了跨醫療環境的安全、可擴展部署。這些工具減少了診斷錯誤，提高了臨床診療效率，並實現了早期療育。

監管機構正在不斷發展，透過自適應核准途徑、實際檢驗要求和上市後績效監測來支援人工智慧的整合。人工智慧工具也正作為電子健康檔案 (EHR)、影像與遠端醫療平台中的整合臨床決策支援系統 (CDSS) 而日益普及，從而推動了其易用性和臨床應用。隨著醫療科技公司、付款人和提供者網路加大對人口健康、個人化醫療和遠距醫療就診的人工智慧診斷的投資，一個關鍵問題正在浮現：基於人工智慧的診斷工具能否實現廣泛的臨床可靠性、互通性和公平的可及性，從而重新定義及時準確的醫療診斷的全球標準？

部分

組件（軟體、服務、硬體、記憶體、其他組件）；應用（放射學、心臟病學、神經病學、腫瘤學、其他應用）；垂直行業（醫院、診斷實驗室、其他垂直行業）

受訪企業範例（共42家）

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP33471

Global Artificial Intelligence-based Medical Diagnostic Tools Market to Reach US$4.8 Billion by 2030

The global market for Artificial Intelligence-based Medical Diagnostic Tools estimated at US$1.7 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the AI Services segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.7 Million While China is Forecast to Grow at 17.9% CAGR

The Artificial Intelligence-based Medical Diagnostic Tools market in the U.S. is estimated at US$445.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$739.3 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.4% and 16.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Artificial Intelligence-Based Medical Diagnostic Tools Market - Key Trends & Drivers Summarized

Why Are AI-Based Diagnostic Tools Reshaping the Medical Decision-Making Landscape?

Artificial Intelligence-based medical diagnostic tools are transforming clinical workflows and healthcare delivery by providing fast, accurate, and scalable diagnostic support across a broad spectrum of medical disciplines. These tools leverage machine learning (ML), deep learning, and natural language processing (NLP) to analyze diverse clinical data-including radiology images, pathology slides, genomic sequences, electronic health records (EHRs), and laboratory test results-to identify patterns, detect anomalies, and generate differential diagnoses with greater consistency and speed than traditional methods. As healthcare systems worldwide grapple with rising patient volumes, workforce shortages, and the demand for precision medicine, AI-powered diagnostics are emerging as indispensable aids for improving diagnostic accuracy and reducing variability in care.

Unlike conventional decision-support systems that rely on static rule sets, AI tools continuously learn and evolve by training on large datasets, often annotated by experts, to provide real-time, evidence-based insights. These systems are being integrated into radiology suites, pathology labs, primary care practices, and telehealth platforms to support early disease detection, triage, and risk stratification. From oncology and cardiology to ophthalmology and dermatology, AI is enabling faster identification of complex conditions-reducing diagnostic delays, enhancing clinical productivity, and facilitating timely interventions that improve patient outcomes.

How Are AI Algorithms Enhancing Diagnostic Performance Across Imaging, Genomics, and Multimodal Data?

AI-based diagnostic tools are revolutionizing medical imaging by interpreting CT scans, MRIs, X-rays, mammograms, and ultrasound images with high precision. Deep convolutional neural networks (CNNs) are widely used for image segmentation, feature extraction, and lesion classification, often outperforming human specialists in specific tasks such as lung nodule detection, breast cancer screening, and diabetic retinopathy grading. These tools not only accelerate image interpretation but also highlight abnormalities with heat maps and explainability features that improve clinical confidence and workflow integration.

In genomics, AI is helping decode complex genetic data for disease risk prediction, rare disease diagnosis, and therapy selection in oncology. Natural language processing algorithms extract clinically relevant data from unstructured EHRs, lab reports, and clinical notes to create comprehensive patient profiles and detect diagnostic signals that may be missed in manual review. Multimodal AI models, which combine imaging, lab values, genetic markers, and patient history, are gaining prominence for their ability to generate holistic diagnostic insights and personalized treatment recommendations. These advances are pushing diagnostic tools beyond single-modality accuracy toward integrative precision diagnostics that support value-based, data-driven care.

Where Is Market Demand Accelerating and Which Clinical Segments Are Leading AI Diagnostic Adoption?

Demand for AI-based medical diagnostic tools is expanding rapidly across the U.S., Europe, and Asia-Pacific, driven by rising healthcare digitization, policy support for AI integration, and growing acceptance among clinicians. North America leads in adoption, supported by advanced health IT infrastructure, favorable reimbursement pilots, and an active ecosystem of medtech startups, academic institutions, and regulatory pathways (e.g., FDA’s AI/ML-based Software as a Medical Device framework). Europe is witnessing increased uptake through national health systems and EU-backed innovation programs. In Asia-Pacific, countries like China, South Korea, Japan, and India are accelerating deployment in hospitals and diagnostics labs, aided by public-private partnerships and AI-centric healthcare reforms.

Radiology remains the most active application area, where AI tools are addressing diagnostic backlogs and enabling teleradiology. Pathology and oncology are key growth segments, with AI aiding in tumor classification, mutation profiling, and biopsy analysis. Cardiology is leveraging AI for ECG interpretation, heart failure risk prediction, and imaging-based structural assessments. Ophthalmology and dermatology are deploying AI for diabetic eye screening and skin lesion analysis, often via mobile or cloud-based solutions. Emerging applications in infectious disease detection (e.g., COVID-19, TB) and point-of-care diagnostics are expanding reach into underserved and rural healthcare environments, where clinician shortages persist.

What Is Driving the Global Growth of AI-Based Medical Diagnostic Tools?

The growth in artificial intelligence-based medical diagnostic tools is driven by the convergence of healthcare digitalization, rising chronic disease burden, and the need for timely, cost-effective diagnostics at scale. A key driver is the increasing availability of structured and unstructured clinical data, coupled with advances in cloud computing, edge AI, and federated learning, which allow for secure, scalable deployment across care settings. These tools reduce diagnostic errors, improve clinical throughput, and enable earlier interventions-aligning with global goals of achieving better outcomes while reducing healthcare costs.

Regulatory bodies are evolving to support AI integration through adaptive approval pathways, real-world validation requirements, and post-market performance monitoring. AI tools are also gaining traction as clinical decision-support systems (CDSS) integrated within EHRs, PACS, and telehealth platforms-enhancing their usability and clinical adoption. As medtech companies, payers, and provider networks increasingly invest in AI diagnostics for population health, personalized medicine, and remote care, a pivotal question surfaces: Can AI-based diagnostic tools achieve widespread clinical trust, interoperability, and equitable access to redefine global standards for timely and precise medical diagnosis?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence-based Medical Diagnostic Tools market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware, Memory, Other Components); Application (Radiology, Cardiology, Neurology, Oncology, Other Applications); Vertical (Hospitals, Diagnostic Laboratories, Other Verticals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence-based Medical Diagnostic Tools - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Early Detection Capabilities Position AI Diagnostic Tools as Frontline Screening Technologies
    • Integration With Imaging Modalities Enhances Diagnostic Accuracy in Radiology and Pathology
    • AI-Based Tools Support Faster Triage and Clinical Decision-Making in Overburdened Healthcare Systems
    • Explainable AI Models Increase Physician Trust in Medical Diagnostic Algorithms
    • Expansion in Cloud-Based Platforms Drives Scalability of AI Diagnostic Tools Across Hospitals
    • Multi-Disease Screening Algorithms Enable Versatile Deployment of AI Medical Diagnostics
    • AI Integration Reduces Diagnostic Error Rates in Complex and Rare Disease Cases
    • Regulatory Approvals for AI Diagnostic Tools Expand Clinical Use in Primary and Secondary Care
    • Workflow Integration With EHRs and PACS Systems Boosts Adoption of AI Diagnostic Technologies
    • Consumer-Facing AI Tools Bridge Gaps in Access to Specialist Diagnostics
    • Telehealth Platforms Leverage AI Diagnostics for Real-Time Remote Evaluation
    • Cross-Specialty Application Potential Strengthens the Long-Term Value of AI-Based Diagnostic Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence-based Medical Diagnostic Tools Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Memory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Memory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Verticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Verticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030

IV. COMPETITION